Medicure Inc. (CVE:MPH – Get Free Report)’s stock price hit a new 52-week low during mid-day trading on Tuesday . The company traded as low as C$0.82 and last traded at C$0.82, with a volume of 500 shares trading hands. The stock had previously closed at C$0.83.
Medicure Stock Down 1.2 %
The firm has a market capitalization of C$8.56 million, a P/E ratio of -3.28 and a beta of 0.90. The company has a fifty day simple moving average of C$0.90 and a 200 day simple moving average of C$0.97. The company has a quick ratio of 1.29, a current ratio of 1.87 and a debt-to-equity ratio of 2.06.
About Medicure
Medicure Inc, a biopharmaceutical company, engages in the research, development, and commercialization of human therapies in the United States. The company markets and distributes AGGRASTAT injection, a glycoprotein GP IIb/IIIa receptor antagonist for the treatment of acute coronary syndrome, including unstable angina and non-Q-wave myocardial infarction.
Featured Stories
- Five stocks we like better than Medicure
- The Top 3 Healthcare Dividend Stocks to Buy and Hold
- SAP’s Strong Momentum: A Bullish Setup for Investors
- Earnings Per Share Calculator: How to Calculate EPS
- BlackRock Breaks Records: Why the Stock Still Has Room to Run
- What Are Earnings Reports?
- Duke vs. NRG: Which Energy Stock Will Power Higher Gains?
Receive News & Ratings for Medicure Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medicure and related companies with MarketBeat.com's FREE daily email newsletter.
